Literature DB >> 16321610

Women in early-phase clinical drug trials: have things changed over the past 20 years?

Jeanette Fleisch1, Markus C Fleisch, Petra A Thürmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16321610     DOI： 10.1016/j.clpt.2005.08.016

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  European Medicines Agency policies for clinical trials leave women unprotected.

Authors:  Maria Teresa Ruiz Cantero; Maria Angeles Pardo
Journal:  J Epidemiol Community Health       Date:  2006-11       Impact factor: 3.710

2.  Sex as a variable in medicines assessment reports for licensing in the European Union. Can gender bias be excluded?

Authors:  N Laguna-Goya; F de Andres-Trelles
Journal:  Eur J Clin Pharmacol       Date:  2014-02-11       Impact factor: 2.953

3.  The emerging science of gender-specific emergency medicine.

Authors:  Alyson J McGregor; Esther Choo
Journal:  R I Med J (2013)       Date:  2015-06-01

4.  Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2011-04-05       Impact factor: 2.953

5.  Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression.

Authors:  Andrea H Weinberger; Sherry A McKee; Carolyn M Mazure
Journal:  J Womens Health (Larchmt)       Date:  2010-09       Impact factor: 2.681

6.  A framework to analyse gender bias in epidemiological research.

Authors:  María Teresa Ruiz-Cantero; Carmen Vives-Cases; Lucía Artazcoz; Ana Delgado; Maria Mar García Calvente; Consuelo Miqueo; Isabel Montero; Rocío Ortiz; Elena Ronda; Isabel Ruiz; Carme Valls
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

Review 7.  Predicting the clinical relevance of drug interactions from pre-approval studies.

Authors:  Silvio Caccia; Silvio Garattini; Luca Pasina; Alessandro Nobili
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Gender analysis of moxifloxacin clinical trials.

Authors:  Elisa Chilet-Rosell; Ma Teresa Ruiz-Cantero; Ma Angeles Pardo
Journal:  J Womens Health (Larchmt)       Date:  2013-11-01       Impact factor: 2.681
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.